
CAS: 2247919-28-2
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | AAPK-25 REF: 54-BUP02392CAS: 2247919-28-2 | ≥95% | 821,00 €~1.621,00 € | Lun 12 May 25 |
![]() | AAPK-25 REF: 3D-XPD91928CAS: 2247919-28-2 | Min. 95% | 331,00 €~1.931,00 € | Vie 20 Jun 25 |
![]() | AAPK-25 REF: TM-T10215CAS: 2247919-28-2 | 97.79% | 95,00 €~2.339,00 € | Vie 11 Jul 25 |

Ref: 54-BUP02392
25mg | 821,00 € | ||
50mg | 1.210,00 € | ||
100mg | 1.621,00 € |
Entrega estimada en Estados Unidos, el Lunes 12 de Mayo de 2025

AAPK-25
CAS:2247919-28-2
Please enquire for more information about AAPK-25 including the price, delivery time and more detailed …
Fórmula:
C30H35ClN4O2
Pureza:
Min. 95%
Peso molecular:
519.1 g/mol
Ref: 3D-XPD91928
1mg | 331,00 € | ||
5mg | 451,00 € | ||
10mg | 721,00 € | ||
25mg | 1.207,00 € | ||
50mg | 1.931,00 € |
Entrega estimada en Estados Unidos, el Viernes 20 de Junio de 2025

AAPK-25
CAS:2247919-28-2
AAPK-25, a dual Aurora/PLK inhibitor, disrupts mitosis, induces apoptosis, and has antitumor properties.
Fórmula:
C21H13Cl2N3O2S
Pureza:
97.79%
Forma y color:
Solid
Peso molecular:
442.32
Ref: TM-T10215
1mg | 95,00 € | ||
5mg | 202,00 € | ||
10mg | 303,00 € | ||
25mg | 550,00 € | ||
50mg | 825,00 € | ||
100mg | 1.198,00 € | ||
1mL*10mM (DMSO) | 233,00 € |
Entrega estimada en Estados Unidos, el Viernes 11 de Julio de 2025